bpc-157 standard dosing protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Mixing and Dosages and
Description
Great experience from the initial call to finishing the product

repeat daily if required
Avoid repeated freeze-thaw cycles, as these can reduce the peptides bioactivity

However, there are certain factors that can trigger a migraine